| Systemic Lupus Erythematosus Research | Lifetime | 29 | US 8 | 99.79 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 21 | US 4 | 99.86 |
| Inflammatory mediators and NSAID effects | Lifetime | 33 | US 16 | 99.58 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 20 | US 11 | 99.09 |
| Bone health and osteoporosis research | Lifetime | 78 | US 41 | 99.50 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 81 | US 40 | 98.93 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 189 | US 102 | 99.42 |
| Bone health and treatments | Lifetime | 123 | US 64 | 99.32 |
| Medication Adherence and Compliance | Lifetime | 46 | US 35 | 98.85 |
| Hip and Femur Fractures | Lifetime | 113 | US 45 | 99.24 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 99 | US 32 | 99.16 |
| Spondyloarthritis Studies and Treatments | Lifetime | 62 | US 17 | 99.17 |
| Bone and Joint Diseases | Lifetime | 117 | US 51 | 98.91 |
| Lymphoma Diagnosis and Treatment | Lifetime | 443 | US 215 | 98.84 |
| Biosimilars and Bioanalytical Methods | Lifetime | 109 | US 42 | 97.77 |
| Hepatitis C virus research | Lifetime | 541 | US 163 | 98.51 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 698 | US 323 | 98.43 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 291 | US 122 | 98.59 |
| Inflammasome and immune disorders | Lifetime | 309 | US 97 | 97.03 |
| Case Reports on Hematomas | Lifetime | 42 | US 16 | 97.18 |
| Opioid Use Disorder Treatment | Lifetime | 259 | US 188 | 97.33 |
| Lipoproteins and Cardiovascular Health | Lifetime | 822 | US 346 | 96.87 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 562 | US 148 | 95.87 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 220 | US 95 | 93.20 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 969 | US 343 | 96.17 |
| Statistical Methods in Clinical Trials | Lifetime | 731 | US 388 | 93.05 |
| Pain Management and Opioid Use | Lifetime | 927 | US 481 | 92.45 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 813 | US 331 | 91.83 |
| Vitamin K Research Studies | Lifetime | 956 | US 374 | 81.35 |
| Pharmaceutical industry and healthcare | Lifetime | 816 | US 462 | 81.11 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 145 | US 33 | 97.59 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 58 | US 16 | 93.28 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 281 | US 74 | 96.05 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 166 | US 68 | 91.26 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 349 | US 73 | 92.24 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 830 | US 341 | 92.13 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 450 | US 61 | 87.45 |
| Case Reports on Hematomas | 2021-2025 | 61 | US 20 | 79.85 |
